Patent US5681852A successfully refreshed from Google Patents.
US5681852A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Desquamation compositions
Assignee: TEXTILE RESEARCH INSTITUTE Inc
•
Filing: 1995-06-07
•
Granted: 1997-10-28
•
Expires: 2015-06-07
Abstract
Abstract The subject invention relates to desquamation compositions comprising a combination of sulfhydryl compounds and zwitterionic surfactants. The subject invention further relates to methods of desquamation in mammalian skin and treating acne in mammalian skin.
Inventors
- 👤 Donald L. Bissett
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 10:03
CPC Classifications
A; A61; A61Q; A61Q19/00; A61K; A61K31/00; A61K31/60; A61K8/00; A61K8/18; A61K8/30; A61K8/33; A61K8/34; A61K8/342; A61K8/37; A61K8/40; A61K8/44; A61K8/442; A61K8/447; A61K8/46; A61K8/55; A61K8/553; A61K8/60; A61K8/64; A61K8/72; A61K8/73; A61K8/731; A61K8/735; A61K8/738; A61K8/81; A61K8/8105; A61K8/8111; A61K8/84; A61K8/86; A61Q19/08; A61Q5/00; A61Q5/006
Claims Analysis
Total Claims: 29
Claim 1
Independent Claim
178 words
A topical composition for desquamation in mammalian skin, comprising: a) desquamation actives comprising: (i) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR14## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof: and (ii) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 2
Dependent Claim
178 words
A topical composition for desquamation in mammalian skin, comprising: a) desquamation actives comprising: (i) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR14## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof: and (ii) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 3
Dependent Claim
30 words
The composition of claim 1 wherein the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically-and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 4
Dependent Claim
18 words
The composition of claim 2 wherein the composition further comprises from about 0.1% to about 10% salicylic acid.
Claim 5
Dependent Claim
51 words
The composition of claim 2 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; and (c) m is 2 or 3.
Claim 6
Dependent Claim
40 words
The composition of claim 4 wherein R 4 has from 1 to about 3 carbon atoms when X is CO 2 , and R 4 has from about 2 to about 4 carbon atoms when X is SO 3 .
Claim 7
Dependent Claim
12 words
The composition of claim 5 wherein the zwitterionic surfactant is behenyl betaine.
Claim 8
Dependent Claim
55 words
The composition of claim 5 wherein: a) R 1 has from about 11 to about 18 carbon atoms; b) R 2 and R 3 are CH 3 ; and c) R 4 has 1 carbon atom when X is CO 2 ; and R 4 has 3 carbon atoms when X is SO 3 .
Claim 9
Dependent Claim
28 words
The composition of claim 7 wherein: (a) R 4 has 3 carbon atoms; (b) X is SO 3 ; (c) m is 3; and (d) n is 1.
Claim 10
Dependent Claim
22 words
The composition of claim 7 wherein the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 11
Dependent Claim
17 words
The composition of claim 9 wherein the zwitterionic surfactant is cocoamidopropyl betaine or cetyl propyl hydroxy sultaine.
Claim 12
Dependent Claim
12 words
The composition of claim 9 wherein the zwitterionic surfactant is cetyl betaine.
Claim 13
Dependent Claim
12 words
The composition of claim 9 wherein the zwitterionic surfactant is stearyl betaine.
Claim 14
Dependent Claim
28 words
The composition of claim 7 wherein: (a) R 4 has 1 carbon atom; (b) X is CO 2 ; (c) m is 3; and (d) n is 1.
Claim 15
Dependent Claim
20 words
The topical composition of claim 1 wherein said desquamation actives consist essentially of said zwitterionic surfactant and said sulfhydryl compound.
Claim 16
Dependent Claim
171 words
A topical composition comprising: (a) from about 0.1% to about 10% of a zwitterionic surfactant having the structure: ##STR15## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof; (b) from about 0.1% to about 20% of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 17
Dependent Claim
171 words
A topical composition comprising: (a) from about 0.1% to about 10% of a zwitterionic surfactant having the structure: ##STR15## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds; and combinations thereof; (b) from about 0.1% to about 20% of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 18
Dependent Claim
28 words
The topical composition of claim 15 comprising from about 0.5% to about 5% of said sulfhydryl compound and from about 0.5% to about 2% of said zwitterionic surfactant.
Claim 19
Independent Claim
187 words
A method of achieving desquamation of mammalian skin comprising topically applying to a mammal in need of such treatment a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR16## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of, CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 20
Independent Claim
187 words
A method of achieving desquamation of mammalian skin comprising topically applying to a mammal in need of such treatment a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR16## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of, CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 21
Dependent Claim
77 words
The method of claim 17 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; (c) m is 2 or 3; and (d) the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 22
Dependent Claim
47 words
The method of claim 18 wherein: (a) the amount of sulfhydryl compound applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin.
Claim 23
Dependent Claim
47 words
The method of claim 19 wherein: (a) the amount of sulfhydryl compound applied is from about 0.02 mg/cm 2 skin to about 0.06 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.02 mg/cm 2 skin to about 0.06 mg/cm 2 skin.
Claim 24
Dependent Claim
31 words
The method of claim 20 wherein; (a) the zwitterionic surfactant is stearyl betaine; and (b) the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 25
Dependent Claim
31 words
The method of claim 20 wherein; (a) the zwitterionic surfactant is cetyl betaine; and (b) the sulfhydryl compound is N-acetyl-L-cysteine, a cosmetically- and/or pharmaceutically-acceptable salt of N-acetyl-L-cysteine, or a combination thereof.
Claim 26
Independent Claim
189 words
A method of treating acne in mammalian skin comprising topically applying to a mammal susceptible to or suffering from ache a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR17## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 27
Independent Claim
189 words
A method of treating acne in mammalian skin comprising topically applying to a mammal susceptible to or suffering from ache a composition comprising: a) a safe and effective amount of a sulfhydryl compound selected from the group consisting of N-acetyl-L-cysteine, glutathione, dithiothreitol, dithioerythritol, homocysteine, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof; and b) a safe and effective amount of a zwitterionic surfactant having the structure: ##STR17## wherein R 1 is unsubstituted, saturated or unsaturated, straight or branched chain alkyl having from about 9 to about 22 carbon atoms; m is an integer from 1 to 3; n is 0 or 1; R 2 and R 3 are, independently, alkyl having from 1 to about 3 carbon atoms, unsubstituted or mono-substituted with hydroxy; R 4 is saturated or unsaturated, straight or branched chain alkyl, unsubstituted or mono-substituted with hydroxy, having from 1 to about 5 carbon atoms; and X is selected from the group consisting of CO 2 , SO 3 and SO 4 ; cosmetically- and/or pharmaceutically-acceptable salts of the foregoing compounds, and combinations thereof; and (c) a cosmetically- and/or pharmaceutically-acceptable topical carrier.
Claim 28
Dependent Claim
77 words
The method of claim 23 wherein: (a) R 2 and R 3 are selected from the group consisting of CH 3 , CH 2 CH 2 OH and CH 2 CH 2 CH 2 OH; (b) X is CO 2 or SO 3 ; (c) m is 2 or 3; and (d) the sulfhydryl compound is selected from the group consisting of N-acetyl-L-cysteine, glutathione, cosmetically- and/or pharmaceutically-acceptable salts of any of the foregoing compounds, and combinations thereof.
Claim 29
Dependent Claim
47 words
The method of claim 24 wherein: (a) the amount of sulfhydryl compound applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin; and (b) the amount of zwitterionic surfactant applied is from about 0.004 mg/cm 2 skin to about 0.1 mg/cm 2 skin.
References Cited (Backward Citations)
US3647834A
Cited
GB1518683A
Cited
US4411886A
Cited
JPS56147708A
Cited
JPS595107A
Cited
EP0281812A1
Cited
EP0299756A2
Cited
US4847071A
Cited
US4847072A
Cited
WO1991017237A1
Cited
US5296500A
Cited
WO1993010755A1
Cited
JPH0692833A
Cited
WO1994005255A1
Cited
WO1994005302A1
Cited
WO1994005279A1
Cited
JPH06135825A
Cited
WO1994009755A1
Cited
JPH06157257A
Cited
WO1995000136A1
Cited
EP0633308A1
Cited
WO1995013048A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-10-27 | 2001-04-28 | 2001-10-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-10-27 | 2005-04-28 | 2005-10-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-10-27 | 2009-04-28 | 2009-10-28 | $7700.00 | Window Closed / Lapsed |